Spinal Muscular Atrophy Clinical Trials in Memphis, Tennessee
4 recruitingMemphis, Tennessee
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Spinal Muscular Atrophy (SMA)
argenx60 enrolled17 locationsNCT07287982
Recruiting
Phase 2
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
Spinal Muscular AtrophySMASpinal Muscular Atrophy Type 3+3 more
Scholar Rock, Inc.52 enrolled25 locationsNCT07047144
Recruiting
Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
Spinal Muscular Atrophy
St. Jude Children's Research Hospital24 enrolled1 locationNCT06532474
Recruiting
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
Novartis Pharmaceuticals700 enrolled99 locationsNCT04174157